| HGNC Family | Solute carriers (SLC) |
| Name | solute carrier family 19 (thiamine transporter), member 2 |
| Description | This gene encodes the thiamin transporter protein. Mutations in this gene cause thiamin-responsive megaloblastic anemia syndrome (TRMA), which is an autosomal recessive disorder characterized by diabetes mellitus, megaloblastic anemia and sensorineural deafness. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2016] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nSLC19A2 encodes thiamine transporter‐1 (THTR1), a high‐affinity, membrane‐bound carrier that is essential for the uptake of thiamine (vitamin B1) into a wide variety of human cells. Thiamine is a critical cofactor for enzymes involved in energy metabolism, and THTR1’s activity in tissues such as the bone marrow, pancreas, retina, and kidney underpins normal cellular function. Disruption of SLC19A2 function by mutations results in the thiamine‐responsive megaloblastic anemia (TRMA) syndrome—a rare autosomal recessive disorder characterized by megaloblastic anemia, diabetes mellitus, and sensorineural deafness."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "7"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAt the molecular level, the SLC19A2 protein is comprised of multiple transmembrane domains that are critical for proper intracellular routing and cell surface expression. Detailed structure–function studies have revealed the importance of both its amino‐terminal and backbone integrity for accurate targeting to the plasma membrane, with distinct cis‐acting promoter elements—such as binding sites for GKLF, NF‑1, and SP‑1—contributing to transcriptional regulation. In addition, post‐translational modifications, including glycosylation, are important for stability and function. Alterations by disease‐causing mutations can impair thiamine uptake by interrupting transporter trafficking or intrinsic transport activity. Such molecular defects not only explain the TRMA phenotype but also suggest that altered SLC19A2 function may broadly disturb thiamine homeostasis in polarized epithelial cells and other tissues."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "8", "end_ref": "29"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond transcriptional and structural regulation, SLC19A2 function is also modulated post‐transcriptionally and in response to environmental cues. Recent studies have uncovered a role for microRNAs (for example, miR‑200a‑3p) in downregulating THTR1 expression in pancreatic acinar cells, thereby impacting thiamine uptake under different metabolic or stress conditions. Similarly, specific mutations and drug interactions further underscore the sensitivity of the SLC19A2 transport process to perturbations, establishing this transporter as a potential target for therapeutic intervention in TRMA and related thiamine insufficiency disorders."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "30", "end_ref": "42"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "William H Lagarde, Louis E Underwood, Billie M Moats-Staats, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Novel mutation in the SLC19A2 gene in an African-American female with thiamine-responsive megaloblastic anemia syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Med Genet A (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ajmg.a.20506"}], "href": "https://doi.org/10.1002/ajmg.a.20506"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14994241"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14994241"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Christopher J Ricketts, Jayne A Minton, Jacob Samuel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Thiamine-responsive megaloblastic anaemia syndrome: long-term follow-up and mutation analysis of seven families."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Acta Paediatr (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/08035250500323715"}], "href": "https://doi.org/10.1080/08035250500323715"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16373304"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16373304"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Birthe S Olsen, Johanne M D Hahnemann, Marianne Schwartz, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Thiamine-responsive megaloblastic anaemia: a cause of syndromic diabetes in childhood."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pediatr Diabetes (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1399-5448.2007.00251.x"}], "href": "https://doi.org/10.1111/j.1399-5448.2007.00251.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17659067"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17659067"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "S Yilmaz Agladioglu, Z Aycan, V N Bas, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Thiamine-responsive megaloblastic anemia syndrome: a novel mutation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genet Couns (2012)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22876572"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22876572"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Enza Mozzillo, Daniela Melis, Mariateresa Falco, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Thiamine responsive megaloblastic anemia: a novel SLC19A2 compound heterozygous mutation in two siblings."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pediatr Diabetes (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1399-5448.2012.00921.x"}], "href": "https://doi.org/10.1111/j.1399-5448.2012.00921.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23289844"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23289844"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Violeta Mikstiene, Jurgita Songailiene, Jekaterina Byckova, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Thiamine responsive megaloblastic anemia syndrome: a novel homozygous SLC19A2 gene mutation identified."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Med Genet A (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ajmg.a.37015"}], "href": "https://doi.org/10.1002/ajmg.a.37015"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25707023"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25707023"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Xin Li, Qing Cheng, Yu Ding, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TRMA syndrome with a severe phenotype, cerebral infarction, and novel compound heterozygous SLC19A2 mutation: a case report."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Pediatr (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12887-019-1608-2"}], "href": "https://doi.org/10.1186/s12887-019-1608-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31296181"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31296181"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "F Thameem, J K Wolford, C Bogardus, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Analysis of slc19a2, on 1q23.3 encoding a thiamine transporter as a candidate gene for type 2 diabetes mellitus in pima indians."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Genet Metab (2001)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1006/mgme.2001.3154"}], "href": "https://doi.org/10.1006/mgme.2001.3154"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11286512"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11286512"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Krishnaswamy Balamurugan, Hamid M Said "}, {"type": "b", "children": [{"type": "t", "text": "Functional role of specific amino acid residues in human thiamine transporter SLC19A2: mutational analysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Gastrointest Liver Physiol (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajpgi.00547.2001"}], "href": "https://doi.org/10.1152/ajpgi.00547.2001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12065289"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12065289"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Xiang Y Liu, Teah L Witt, Larry H Matherly "}, {"type": "b", "children": [{"type": "t", "text": "Restoration of high-level transport activity by human reduced folate carrier/ThTr1 thiamine transporter chimaeras: role of the transmembrane domain 6/7 linker region in reduced folate carrier function."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem J (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BJ20020419"}], "href": "https://doi.org/10.1042/BJ20020419"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12227830"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12227830"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Veedamali S Subramanian, Jonathan S Marchant, Ian Parker, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cell biology of the human thiamine transporter-1 (hTHTR1). Intracellular trafficking and membrane targeting mechanisms."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M210717200"}], "href": "https://doi.org/10.1074/jbc.M210717200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12454006"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12454006"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Jack C Reidling, Hamid M Said "}, {"type": "b", "children": [{"type": "t", "text": "In vitro and in vivo characterization of the minimal promoter region of the human thiamin transporter SLC19A2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Cell Physiol (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajpcell.00076.2003"}], "href": "https://doi.org/10.1152/ajpcell.00076.2003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12900388"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12900388"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Svetlana M Nabokina, Jack C Reidling, Hamid M Said "}, {"type": "b", "children": [{"type": "t", "text": "Differentiation-dependent up-regulation of intestinal thiamin uptake: cellular and molecular mechanisms."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M505243200"}], "href": "https://doi.org/10.1074/jbc.M505243200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16055442"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16055442"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Veedamali S Subramanian, Jonathan S Marchant, Hamid M Said "}, {"type": "b", "children": [{"type": "t", "text": "Targeting and trafficking of the human thiamine transporter-2 in epithelial cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M512765200"}], "href": "https://doi.org/10.1074/jbc.M512765200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16371350"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16371350"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Balasubramaniem Ashokkumar, Nosratola D Vaziri, Hamid M Said "}, {"type": "b", "children": [{"type": "t", "text": "Thiamin uptake by the human-derived renal epithelial (HEK-293) cells: cellular and molecular mechanisms."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Renal Physiol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajprenal.00078.2006"}], "href": "https://doi.org/10.1152/ajprenal.00078.2006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16705148"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16705148"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Lisa Mee, Svetlana M Nabokina, V Thillai Sekar, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Pancreatic beta cells and islets take up thiamin by a regulated carrier-mediated process: studies using mice and human pancreatic preparations."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Gastrointest Liver Physiol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajpgi.00092.2009"}], "href": "https://doi.org/10.1152/ajpgi.00092.2009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19423748"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19423748"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Ya-Ping Liao, Ming-Sheng Bao, Chang-Qing Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "[Folate gene polymorphism and the risk of Down syndrome pregnancies in young Chinese women]."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Yi Chuan (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3724/sp.j.1005.2010.00461"}], "href": "https://doi.org/10.3724/sp.j.1005.2010.00461"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20466634"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20466634"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Charles Shaw-Smith, Sarah E Flanagan, Ann-Marie Patch, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Recessive SLC19A2 mutations are a cause of neonatal diabetes mellitus in thiamine-responsive megaloblastic anaemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pediatr Diabetes (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1399-5448.2012.00855.x"}], "href": "https://doi.org/10.1111/j.1399-5448.2012.00855.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22369132"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22369132"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "James R Larkin, Fang Zhang, Lisa Godfrey, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Glucose-induced down regulation of thiamine transporters in the kidney proximal tubular epithelium produces thiamine insufficiency in diabetes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0053175"}], "href": "https://doi.org/10.1371/journal.pone.0053175"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23285265"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23285265"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Aria Setoodeh, Amirreza Haghighi, Nasrollah Saleh-Gohari, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of a SLC19A2 nonsense mutation in Persian families with thiamine-responsive megaloblastic anemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gene (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.gene.2013.02.008"}], "href": "https://doi.org/10.1016/j.gene.2013.02.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23454484"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23454484"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Belén Pérez-Dueñas, Mercedes Serrano, Mónica Rebollo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Reversible lactic acidosis in a newborn with thiamine transporter-2 deficiency."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pediatrics (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1542/peds.2012-2988"}], "href": "https://doi.org/10.1542/peds.2012-2988"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23589815"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23589815"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Natarajan N Srikrupa, Swaminathan Meenakshi, Tharigopala Arokiasamy, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Leber's congenital amaurosis as the retinal degenerative phenotype in thiamine responsive megaloblastic anemia: a case report."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ophthalmic Genet (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3109/13816810.2013.793363"}], "href": "https://doi.org/10.3109/13816810.2013.793363"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23638917"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23638917"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Jason A Zastre, Bradley S Hanberry, Rebecca L Sweet, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Up-regulation of vitamin B1 homeostasis genes in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Nutr Biochem (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jnutbio.2013.02.002"}], "href": "https://doi.org/10.1016/j.jnutbio.2013.02.002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23642734"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23642734"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Nosrat Ghaemi, Martha Ghahraman, Mohammad Reza Abbaszadegan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Novel mutation in the SLC19A2 gene in an Iranian family with thiamine-responsive megaloblastic anemia: a series of three cases."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Res Pediatr Endocrinol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4274/Jcrpe.969"}], "href": "https://doi.org/10.4274/Jcrpe.969"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24072090"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24072090"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Mohammad Taghi Akbari, Shohreh Zare Karizi, Reza Mirfakhraie, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Thiamine-responsive megaloblastic anemia syndrome with Ebstein anomaly: a case report."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Pediatr (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00431-013-2237-7"}], "href": "https://doi.org/10.1007/s00431-013-2237-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24357267"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24357267"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Kuixing Zhang, Matthew J Huentelman, Fangwen Rao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic implication of a novel thiamine transporter in human hypertension."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Am Coll Cardiol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jacc.2014.01.007"}], "href": "https://doi.org/10.1016/j.jacc.2014.01.007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24509276"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24509276"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Dyego O de Miranda, Jemima E X S Barros, Maria Madalena S Vieira, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Reduced folate carrier-1 G80a gene polymorphism is associated with neuroblastoma's development."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Biol Rep (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11033-014-3372-6"}], "href": "https://doi.org/10.1007/s11033-014-3372-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24771227"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24771227"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Prapaporn Jungtrakoon, Jun Shirakawa, Patinut Buranasupkajorn, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Loss-of-Function Mutation in Thiamine Transporter 1 in a Family With Autosomal Dominant Diabetes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetes (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2337/db17-0821"}], "href": "https://doi.org/10.2337/db17-0821"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30833467"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30833467"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Takahiro Yamashiro, Tomoya Yasujima, Hamid M Said, et al. "}, {"type": "b", "children": [{"type": "t", "text": "pH-dependent pyridoxine transport by SLC19A2 and SLC19A3: Implications for absorption in acidic microclimates."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.RA120.013610"}], "href": "https://doi.org/10.1074/jbc.RA120.013610"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33008889"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33008889"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Hamid M Said, Krishnaswamy Balamurugan, Veedamali S Subramanian, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression and functional contribution of hTHTR-2 in thiamin absorption in human intestine."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Gastrointest Liver Physiol (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajpgi.00361.2003"}], "href": "https://doi.org/10.1152/ajpgi.00361.2003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14615284"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14615284"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Dana Baron, Yehuda G Assaraf, Stavit Drori, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Disruption of transport activity in a D93H mutant thiamine transporter 1, from a Rogers Syndrome family."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Biochem (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1046/j.1432-1033.2003.03839.x"}], "href": "https://doi.org/10.1046/j.1432-1033.2003.03839.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14622275"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14622275"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Li-jun Pei, Hui-ping Zhu, Zhi-wen Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Interaction between maternal periconceptional supplementation of folic acid and reduced folate carrier gene polymorphism of neural tube defects."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Zhonghua Yi Xue Yi Chuan Xue Za Zhi (2005)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15952116"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15952116"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Veedamali S Subramanian, Jonathan S Marchant, Hamid M Said "}, {"type": "b", "children": [{"type": "t", "text": "Targeting and intracellular trafficking of clinically relevant hTHTR1 mutations in human cell lines."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Sci (Lond) (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/CS20060331"}], "href": "https://doi.org/10.1042/CS20060331"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17331069"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17331069"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Veedamali S Subramanian, Zainab M Mohammed, Andres Molina, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Vitamin B1 (thiamine) uptake by human retinal pigment epithelial (ARPE-19) cells: mechanism and regulation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Physiol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1113/jphysiol.2007.128843"}], "href": "https://doi.org/10.1113/jphysiol.2007.128843"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17463047"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17463047"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Anke K Bergmann, Dean R Campagna, Erin M McLoughlin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Systematic molecular genetic analysis of congenital sideroblastic anemia: evidence for genetic heterogeneity and identification of novel mutations."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pediatr Blood Cancer (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/pbc.22244"}], "href": "https://doi.org/10.1002/pbc.22244"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19731322"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19731322"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Chengjun Sun, Zhou Pei, Miaoying Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Recovered insulin production after thiamine administration in permanent neonatal diabetes mellitus with a novel solute carrier family 19 member 2 (SLC19A2) mutation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Diabetes (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/1753-0407.12556"}], "href": "https://doi.org/10.1111/1753-0407.12556"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28371426"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28371426"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Xiaoying Xian, Lin Liao, Wei Shu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A Novel Mutation of SLC19A2 in a Chinese Zhuang Ethnic Family with Thiamine-Responsive Megaloblastic Anemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Physiol Biochem (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000491467"}], "href": "https://doi.org/10.1159/000491467"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29969779"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29969779"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Işık Odaman-Al, Alper Gezdirici, Melek Yıldız, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A novel mutation in the SLC19A2 gene in a Turkish male with thiamine-responsive megaloblastic anemia syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Turk J Pediatr (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.24953/turkjped.2019.02.015"}], "href": "https://doi.org/10.24953/turkjped.2019.02.015"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31951336"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31951336"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Tae-Keun Ahn, Jung Oh Kim, Hui Jeong An, et al. "}, {"type": "b", "children": [{"type": "t", "text": "3'-UTR Polymorphisms of Vitamin B-Related Genes Are Associated with Osteoporosis and Osteoporotic Vertebral Compression Fractures (OVCFs) in Postmenopausal Women."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genes (Basel) (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/genes11060612"}], "href": "https://doi.org/10.3390/genes11060612"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32498429"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32498429"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Kalidas Ramamoorthy, Kasin Yadunandam Anandam, Tomoya Yasujima, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Posttranscriptional regulation of thiamin transporter-1 expression by microRNA-200a-3p in pancreatic acinar cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Gastrointest Liver Physiol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajpgi.00178.2020"}], "href": "https://doi.org/10.1152/ajpgi.00178.2020"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32683950"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32683950"}]}, {"type": "r", "ref": 41, "children": [{"type": "t", "text": "Osatohanmwen J Enogieru, Megan L Koleske, Bianca Vora, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The Effects of Genetic Mutations and Drugs on the Activity of the Thiamine Transporter, SLC19A2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "AAPS J (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1208/s12248-021-00562-4"}], "href": "https://doi.org/10.1208/s12248-021-00562-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33649974"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33649974"}]}, {"type": "r", "ref": 42, "children": [{"type": "t", "text": "Neda Mohsen-Pour, Niloofar Naderi, Serwa Ghasemi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Whole-Exome Sequencing Revealed a Pathogenic Nonsense Variant in the SLC19A2 Gene in an Iranian Family with Thiamine-Responsive Megaloblastic Anemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Lab Med (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/labmed/lmac040"}], "href": "https://doi.org/10.1093/labmed/lmac040"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35686496"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35686496"}]}]}]}
|
| Synonyms | THMD1, TRMA, THTR1, THT1 |
| Proteins | S19A2_HUMAN |
| NCBI Gene ID | 10560 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
SLC19A2 has 8,803 functional associations with biological entities spanning 9 categories (molecular profile, organism, chemical, disease, phenotype or trait, functional term, phrase or reference, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 124 datasets.
Click the + buttons to view associations for SLC19A2 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Achilles Cell Line Gene Essentiality Profiles | cell lines with fitness changed by SLC19A2 gene knockdown relative to other cell lines from the Achilles Cell Line Gene Essentiality Profiles dataset. | |
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of SLC19A2 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of SLC19A2 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SLC19A2 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of SLC19A2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of SLC19A2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of SLC19A2 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of SLC19A2 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SLC19A2 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SLC19A2 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of SLC19A2 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of SLC19A2 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of SLC19A2 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with SLC19A2 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of SLC19A2 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of SLC19A2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of SLC19A2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| ClinVar Gene-Phenotype Associations | phenotypes associated with SLC19A2 gene from the curated ClinVar Gene-Phenotype Associations dataset. | |
| ClinVar Gene-Phenotype Associations 2025 | phenotypes associated with SLC19A2 gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset. | |
| CM4AI U2OS Cell Map Protein Localization Assemblies | assemblies containing SLC19A2 protein from integrated AP-MS and IF data from the CM4AI U2OS Cell Map Protein Localization Assemblies dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SLC19A2 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing SLC19A2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing SLC19A2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Experimental Protein Localization Evidence Scores | cellular components containing SLC19A2 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 | cellular components containing SLC19A2 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with SLC19A2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with SLC19A2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of SLC19A2 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with SLC19A2 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with SLC19A2 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with SLC19A2 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of SLC19A2 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by SLC19A2 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Curated Gene-Disease Association Evidence Scores | diseases involving SLC19A2 gene from the DISEASES Curated Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Curated Gene-Disease Association Evidence Scores 2025 | diseases involving SLC19A2 gene from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with SLC19A2 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with SLC19A2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with SLC19A2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with SLC19A2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with SLC19A2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| DrugBank Drug Targets | interacting drugs for SLC19A2 protein from the curated DrugBank Drug Targets dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at SLC19A2 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of SLC19A2 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of SLC19A2 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing SLC19A2 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with SLC19A2 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with SLC19A2 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of SLC19A2 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with SLC19A2 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing SLC19A2 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of SLC19A2 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of SLC19A2 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of SLC19A2 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SLC19A2 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of SLC19A2 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of SLC19A2 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving SLC19A2 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving SLC19A2 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving SLC19A2 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing SLC19A2 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by SLC19A2 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by SLC19A2 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by SLC19A2 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of SLC19A2 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of SLC19A2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of SLC19A2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SLC19A2 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| Guide to Pharmacology Chemical Ligands of Receptors | ligands (chemical) binding SLC19A2 receptor from the curated Guide to Pharmacology Chemical Ligands of Receptors dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with SLC19A2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with SLC19A2 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with SLC19A2 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of SLC19A2 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HMDB Metabolites of Enzymes | interacting metabolites for SLC19A2 protein from the curated HMDB Metabolites of Enzymes dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of SLC19A2 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of SLC19A2 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of SLC19A2 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SLC19A2 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| HPO Gene-Disease Associations | phenotypes associated with SLC19A2 gene by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with SLC19A2 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for SLC19A2 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of SLC19A2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of SLC19A2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of SLC19A2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEGG Pathways 2026 | pathways involving SLC19A2 protein from the KEGG Pathways 2026 dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of SLC19A2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of SLC19A2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with SLC19A2 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of SLC19A2 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of SLC19A2 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of SLC19A2 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SLC19A2 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing SLC19A2 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain SLC19A2 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by SLC19A2 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting SLC19A2 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of SLC19A2 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of SLC19A2 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by SLC19A2 gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of SLC19A2 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of SLC19A2 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| OMIM Gene-Disease Associations | phenotypes associated with SLC19A2 gene from the curated OMIM Gene-Disease Associations dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for SLC19A2 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of SLC19A2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of SLC19A2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving SLC19A2 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving SLC19A2 protein from the Wikipathways PFOCR 2024 dataset. | |
| Reactome Pathways 2014 | pathways involving SLC19A2 protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving SLC19A2 protein from the Reactome Pathways 2024 dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SLC19A2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at SLC19A2 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of SLC19A2 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of SLC19A2 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of SLC19A2 gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of SLC19A2 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of SLC19A2 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of SLC19A2 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of SLC19A2 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of SLC19A2 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of SLC19A2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of SLC19A2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of SLC19A2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with SLC19A2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with SLC19A2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2024 | pathways involving SLC19A2 protein from the WikiPathways Pathways 2024 dataset. | |